Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q2 2024 Earnings

6MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-0.83

-0.74

-0.65

-0.56

Details

Expected EPS

-0.692857

Actual EPS

-0.56

Surprise EPS

0.13

Surprise Percent

+19.18%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.56 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.